Description

This richly illustrated, comprehensive guide will enable the reader to identify anatomy and ophthalmic disease as illustrated on optical coherence tomography (OCT). It is the most up-to-date atlas of OCT images, many of which have been obtained with the newer OCT technologies that offer excellent image quality and definition at a microscopic level. All of the major disease areas in ophthalmology are covered, including diabetic retinopathy, age-related macular degeneration, uveitis, glaucoma, retinal vascular disease, and genetic abnormalities, and further hot topics are also considered. The chapters are written by leading international ophthalmologists from famous academic centers, and the numerous high-quality OCT images ensure that the reader will easily be able to follow the key issues. This book, with its clinical emphasis, will have wide appeal for residents, fellows, and experienced practitioners in ophthalmology, as well as optometrists and medical students and graduates.​

Reviews

Let there be light’. Or more precisely, deliver the needed wavelength at appropriate power, with high temporal and spatial resolution if you want to figure out how brain circuits work. This volume has many excellent chapters and the right toolbox for the job.’ György Buzsáki, Neuroscience Institute and Langone Medical Center, New York University
‘Optogenetics is a unique compilation of articles by some of the key experts in the field covering the entire breadth of topics from molecular mechanisms, via hands-on application tips all the way to clinical use and ethical implications as well as a detailed and accurate historical perspective. For this still rapidly developing field it will become a must-read and core reference for novices and experts alike.’ Andreas Schaefer, he Francis Crick Institute, London

‘Both the expert and novice, alike, will find this to be a valuable resource that covers multiple aspects of the Optogenetics field, from its history through to current scientific and potential clinical applications.’ Michelle M. Sidor, Novartis Institutes for Biomedical Research, Massachusetts